Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment.
Wang X, Wang L, Liu W, Liu X, Jia X, Feng X, Li F, Zhu R, Yu J, Zhang H, Wu H, Wu J, Wang C, Yu B, Yu X.
Wang X, et al. Among authors: wang l, wang c.
J Exp Clin Cancer Res. 2023 Aug 22;42(1):216. doi: 10.1186/s13046-023-02795-x.
J Exp Clin Cancer Res. 2023.
PMID: 37605148
Free PMC article.